HG

Hiege-Stiftung gegen Hautkrebs

Deutsche Hautkrebsstiftung Fleur Hiege

Hamburg, Germany

Medical researchHealthTax-deductible donations
Grant-making foundationFounded 2006National reach
Profile last updated: October 10, 2026

About

Founded in 2006, Hiege-Stiftung gegen Hautkrebs is a grant-making foundation based in Hamburg, Germany working on medical research, health.

The Hiege-Stiftung gegen Hautkrebs, also known as the Deutsche Hautkrebsstiftung Fleur Hiege, is a German foundation established in 2006 by the Hiege family after their daughter Fleur died of malignant melanoma at age 32. It funds scientific research into the diagnosis and treatment of skin cancer, particularly malignant melanoma, through annual research grants, typically between 20,000 and 50,000 euros, awarded to researchers at German university hospitals and research institutions. It also runs the Fleur Hiege-Gedächtnispreis for young researchers, supports habilitation fellowships, and funded the Fleur Hiege-Centrum für Hautkrebsforschung at the UKE in Hamburg. The foundation provides patient information, including a guide for affected people and their relatives, a directory of dermatologists and dermatology clinics, and peer support contacts. Its administrative costs are covered from asset income, so donations go entirely to funded projects. In 2020 it took over the Deutsche Hautkrebs-Stiftung based in Frankfurt and added that name to its own. The foundation is based in Hamburg and operates in Germany.

Location

Hamburg, Germany

Founded

2006

Organisation type

Grant-making foundation

Legal form

Rechtsfähige Stiftung bürgerlichen Rechts

Legal name

Deutsche Hautkrebsstiftung Fleur Hiege

VAT number

DE032003000

Focus areas

melanomaskin cancermedical researchfoundationliquid biopsyimmunotherapy

Languages

DE

Causes & programmes

Causes

Medical researchHealth

Works for

PatientsCarers

How they work

Grant-makingAwareness & education

Programmes

Fleur Hiege-Centrum für Hautkrebsforschung

View

Medical research · Germany

Research centre at the Universitätsklinikum Hamburg-Eppendorf (UKE), opened in 2022, operated with the Institut für Tumorbiologie. Initially focused on liquid biopsy research for skin cancer, especially malignant melanoma.

Countries of operation

Germany

Funding & support

Funded by

Individual donations

Ways to support

Donate

Trust

Tax-deductible donations

Credentials & affiliations

Awards

Young Investigator Award

European Liquid Biopsy Society2023

Industry memberships

Bundesverband Deutscher StiftungenArbeitsgemeinschaft Dermatologische OnkologieArbeitsgemeinschaft Dermatologische Prävention e.V.Nationale Versorgungskonferenz Hautkrebs

Partnerships

Johannes Wesling Klinikum Minden, Universitätsklinikum Hamburg-Eppendorf, Ruhr-Universität Bochum

Other non-profits in Germany

View all